1. GPCR/G Protein Neuronal Signaling
  2. 5-HT Receptor
  3. AZD3783

AZD3783 is an orally active, blood-brain barrier-penetrant 5-HT1B receptor antagonist. AZD3783 reverses agonist-induced hypothermia, inhibits separation-induced vocalizations in guinea pig pups, and acts as a moderately permeable glycoprotein substrate with moderate clearance. AZD3783 inhibits hERG channel activity. AZD3783 is applicable for research on depression, anxiety disorders, and other psychiatric diseases associated with serotonergic neurotransmission.

For research use only. We do not sell to patients.

AZD3783

AZD3783 Chemical Structure

CAS No. : 1162658-64-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

AZD3783 is an orally active, blood-brain barrier-penetrant 5-HT1B receptor antagonist. AZD3783 reverses agonist-induced hypothermia, inhibits separation-induced vocalizations in guinea pig pups, and acts as a moderately permeable glycoprotein substrate with moderate clearance. AZD3783 inhibits hERG channel activity. AZD3783 is applicable for research on depression, anxiety disorders, and other psychiatric diseases associated with serotonergic neurotransmission[1][2].

IC50 & Target[1]

5-HT1B Receptor

12.5 nM (Ki)

In Vitro

AZD3783 (Compound 1a) binds to human 5-HT1B receptors expressed on CHO cell membranes, with a Ki value of 12 nM[1].
AZD3783 (1 h) acts as a functional antagonist of the 5-HT1B receptor expressed on human CHO cell membranes, and produces 120% inhibition of 5-HT-stimulated GTPγS binding[1].
AZD3783 inhibits hERG channel activity in cell-based in vitro assays, with an IC50 of 19 μM and a maximal effect of 81% at a concentration of 100 μM[1].
AZD3783 (300 μM) exhibits pro-phospholipidogenic activity in in vitro cell assays, producing 81% of the maximum effect at a concentration of 300 μM[1].
AZD3783 (170 pM-10 μM; 1 h) exhibits high affinity for recombinant human 5-HT1B receptor, with a Ki value of 12.5 nM[2].
AZD3783 (170 pM-10 μM; 1 h) exhibits high affinity for recombinant guinea pig 5-HT1B receptors, with a Ki value of 11.1 nM[2].
AZD3783 (170 pM-10 μM; 1 h) is a reversible competitive antagonist of the recombinant human 5-HT1B receptor, with an EC50 of 42 nM for inhibiting 5-HT-induced GTPγ[35S] binding[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics
Species Dose Route AUC0-∞ CLplasma Vdss T1/2 Cmax Tmax Bioavailability
Rat[2] 10 μmol/Kg i.v. 8.8 μM·h 19 mL/min/kg 2.3 L/kg 1.4 h / / /
Rat[2] 30 μmol/Kg p.o. 26 μM·h / / / 9.5 μM 0.25 h 98 %
Dog[2] 2.0 μmol/Kg i.v. 1.9 μM·h 18 mL/min/kg 4.3 L/kg 3.7 h / / /
Dog[2] 2.0 μmol/Kg p.o. 1.1 μM·h / / / 0.24 μM 1.00 h 58 %
Monkey[2] 3.0 μmol/Kg i.v. 1.5 μM·h 35 mL/min/kg 5.9 L/kg 4.6 h / / /
In Vivo

AZD3783 (0.002-20 μM/kg; subcutaneous injection; single administration) blocks 5-HT1B agonist-induced hypothermia in guinea pigs, with a free plasma EC50 of 18 nM, and achieves dose-dependent 5-HT1B receptor occupancy in guinea pig brains, with a mean free plasma EC50 of 11 nM[2].
AZD3783 (0.2-2.0 μmol/kg; subcutaneous injection; single administration) reduces separation-induced vocalizations in guinea pig pups at doses as low as 0.2 μmol/kg, exhibiting anxiolytic-like activity[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Dunkin-Hartley (adult, male, body weight 0.2 to 0.4 kg)[2]
Dosage: 0.002, 0.006, 0.06, 0.2, 0.6, 2, 6, 20 μM/kg
Administration: s.c.; single dose
Result: Reversed CP135.807-induced hypothermia in a dose-dependent manner.
Achieved an unbound plasma EC50 of 18 nM for blockade of hypothermia.
Achieved an unbound brain EC50 of 16 nM for blockade of hypothermia.
Animal Model: Dunkin-Hartley (pups, 4 to 6 days postnatal to 23 to 25 days postnatal)[2]
Dosage: 0.2, 0.6, 2.0 μM/kg
Administration: s.c.; single dose per test session
Result: Significantly decreased separation-induced vocalizations overall.
Produced significant reductions in vocalizations at all tested doses.
Demonstrated a minimum efficacious dose at or below 0.2 μM/kg.
Molecular Weight

466.57

Formula

C26H34N4O4

CAS No.
SMILES

O=C([C@@H]1OC2=C(N3CCN(CC3)C)C=C(C=C2CC1)OC)NC4=CC=C(N5CCOCC5)C=C4

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
AZD3783
Cat. No.:
HY-182440
Quantity:
MCE Japan Authorized Agent: